Business Wire

Philip Morris International Bolsters Washington, D.C., Presence with Key Staff Appointments

Share

Philip Morris International’s (PMI) Washington, D.C., operations are being strengthened with two key personnel moves. J.B. Simko has been promoted to Vice President External Affairs and will relocate from New York to serve in his new role as head of the Washington, D.C., office. Aaron Sherinian, who has been serving in his role of Vice President Global Communications Transformation from Paris since he joined the company in September 2018, will relocate to work in the D.C. office as well.

“We are very pleased to have J.B. and Aaron representing PMI in Washington,” said Marc Firestone, President External Affairs and General Counsel. “They are both powerhouse team players, and we believe their presence in D.C.—where regulatory and policymakers meet—will send the positive message that we are working to make our vision of a smoke-free future a reality in the U.S. and abroad.”

Simko has been with PMI since 2001, and he will continue to work for Firestone and Livio Vanghetti, Vice President of Global Partnerships and Cooperation, on external affairs.

“We congratulate J.B. on his well-deserved promotion,” said Vanghetti. “This strategic strengthening of our Washington, D.C., office will serve as an advantage in building PMI’s capabilities for future-facing communications, constructive engagement with civil society and alliances for global social good.”

“This is a rewarding role, and I am very happy to be continuing in my expanded position as we ramp up our efforts to build a smoke-free future,” Simko added.

Sherinian will continue to work on transformation for the existing Global Communications team, led by Marian Salzman, Senior Vice President Global Communications, and on regulatory and scientific communications for Moira Gilchrist, Vice President of Scientific and Public Communications, who leads PMI’s FDA-related communications.

“In just a few months, Aaron has proved himself as integral to our Global Communications division, as we work to bring about one of the greatest corporate transformations in history, with historic potential to generate public health benefits for millions of adults who smoke around the world,” said Salzman. “This team is telling the story of PMI’s vision of a smoke-free future as part of genuine dialogues that exert intelligent influence.”

Said Sherinian: “This assignment is the professional challenge of a lifetime, and it’s one that I wholeheartedly embrace. Being in Washington, D.C., will be a real advantage in building PMI’s capabilities for future-facing communications, constructive engagement with civil society and alliances for global social good.”

Before being appointed to his current position, J.B. Simko was vice president and associate general counsel, litigation, managing litigation of company-wide significance on behalf of PMI entities globally. In this role, Simko also became deeply involved in developing regulatory strategies related to FDA authorization of new and modified risk tobacco products.

During the course of his career with PMI, Simko has provided legal support across many business functions, including Next Generation Products, Research & Development, Communications, Sales, Marketing and Motorsports, Brand Integrity, and Compliance.

He is a graduate of the University of Minnesota Law School (JD, magna cum laude and Order of the Coif) and a graduate of the University of Iowa (BS, Psychology).

Before joining PMI, Aaron Sherinian served as global communications director for the Aga Khan Development Network (AKDN) from 2017 to 2018, responsible for coordination, messaging, media relations and digital communications for a worldwide network including over 80,000 employees and a mission to help improve quality of life for people around the world.

Sherinian served as chief communications and marketing officer for the United Nations Foundation through a period of intense global challenge and change. During his tenure at the foundation (2009-2017), the communications team won multiple awards, including being named “PR Team of the Year” by PR News. Sherinian was named by PRWeek as “Global Communicator of the Year” in 2015.

Earlier in his career, Sherinian was managing director of public affairs for the Millennium Challenge Corporation, a U.S. government development assistance agency administering $7 billion in poverty reduction grants in 40 partner countries, and served as a foreign service officer for the U.S. Department of State.

He holds degrees from the Johns Hopkins University (School of Advanced International Studies) and Brigham Young University.

Philip Morris International: Building a Smoke-Free Future

Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company and its shareholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, smoke-free products and associated electronic devices and accessories, and other nicotine-containing products in markets outside the U.S. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, PMI aims to ensure that its smoke-free products meet adult consumer preferences and rigorous regulatory requirements. PMI's smoke-free IQOS product portfolio includes heated tobacco and nicotine-containing vapor products. As of Dec. 31, 2018, PMI estimates that approximately 6.6 million adult smokers around the world have already stopped smoking and switched to PMI’s heated tobacco product, which is currently available for sale in 44 markets in key cities or nationwide under the IQOS brand. For more information, see our PMI and PMIScience websites.

# # #

Contact information

Philip Morris International Media Office
Corey Henry
T. +1 202-777-4304
Corey.Henry@pmi.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

NetMedia Group takes over the management of financial platform Investing.com's European advertising space23.7.2019 08:07:00 CESTPress release

NetMedia Group, media B2B leader in Europe in the world of business information, and Investing.com, second largest financial services and information platform in Europe, are to form a partnership, with NetMedia Group handling the sales of advertising space for Investing.com. With average traffic of over 21 million unique users totaling over 175 million sessions in 31 countries, Investing.com is one of the top three global financial websites and has the most downloaded financial management app. For Investing.com, the aim of the new partnership is to maximize digital advertising revenue through the NetMedia Group's European teams. NetMedia Group's goal is to expand its advertising services by offering a new vertical market for finance, in order to boost the range of services it has available to decision-makers for upper socio-professional target groups. About NetMedia Group: NetMedia Group is a B2B media group located in five countries across Europe; it employs nearly 150 staff members a

Frost & Sullivan Names Luminati the 2019 Global Market Leader in the Enterprise IP Proxy Networks Market23.7.2019 08:00:00 CESTPress release

Luminati, the Israeli company that allows businesses to experience the web through the eyes of individual consumers throughout the world, today announced it has received a Market Leadership Award in the first independent analysis of the sector. Luminati’s enterprise IP proxy network (IPPN) services for global retailers, brand owners and advertising networks feature strongly in the report by analyst firm Frost & Sullivan. The report outlines a relatively new, but rapidly growing market and recognizes Luminati’s leading position in the provision of solutions that are increasingly important for businesses to remain competitive and compliant in the digital landscape. [S1] “The market for enterprise IP proxy network solutions is in its early growth stages, basically being invented by Luminati only a few years ago. With the more specialized targeting of customers by demographics and location, companies are finding it more difficult than ever to do competitive analysis and verify advertising,

LifeSpan BioSciences Releases Best-In-Class PathPlus™ Top Performing Immunohistochemistry Antibodies for Cancer Targets23.7.2019 08:00:00 CESTPress release

LifeSpan BioSciences, Inc. (LSBio™), the industry leader in molecular pathology, today announced the first release of its PathPlus™ series of antibodies. These 565 antibodies were selected from among thousands tested and identified to be the best performing reagents for immunohistochemical detection of 200 high-value cancer targets in formalin-fixed paraffin-embedded human tissues. Antibody validation has become an industry roadblock as thousands of antibodies have become available to customers who face difficult choices in determining which antibodies are the best performers for each application, including immunohistochemistry, flow cytometry, ELISA, Western blot, or immunofluorescence. Antibodies that perform well in one assay, such as IHC, may not be the most specific reagent for another assay, such as flow cytometry. “Identifying the optimal reagents to use in their experiments is a pain point for researchers,” said LSBio CEO Heather Holemon. “There is a tremendous need to identify

IDEMIA Will Present Its H1 2019 Financial Results to Investors on July 30, 201923.7.2019 07:00:00 CESTPress release

IDEMIA, the world leader in Augmented Identity, today announced that it will present its H1 2019 financial results to investors on Tuesday July 30, 2019. Yann Delabrière (CEO) and Laurent Lemaire (CFO) will be presenting the financial results and taking questions the same day at 3:30 pm CET (2:30 pm London Time / 9:30 am New York Time). For more information, please refer to our website: https://investors.idemia.com/ About IDEMIA IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space. Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whet

Gain Therapeutics SA Announces Award Notification of a €1.4M Grant Support From Eurostars-2 Together With the Institute for Research in Biomedicine and Neuro-Sys SAS After Having Scored 2nd Among 325 Eligible Applications23.7.2019 06:30:00 CESTPress release

Gain Therapeutics SA, a biotechnology company discovering and developing novel therapeutics to target lysosomal enzymes involved in inborn errors of metabolism and in central nervous system (CNS) diseases, today announced that together with Dr. Maurizio Molinari from the Institute for Research in Biomedicine, Bellinzona (Switzerland) affiliated to the Università della Svizzera italiana (USI) and Neuro-Sys SAS in Gardanne (France), it has received funding support from Eurostars-2 joint programme with co-funding from the European Union Horizon 2020 research and Innosuisse – Swiss Innovation Agency. This grant will further strengthen Gain Therapeutics’s novel therapeutic approach for targeting rare diseases in the CNS, where lysosomal misfolded enzymes lead to sever clinical phenotypes, where no treatment is available and/or high unmet medical needs still do afflict patients, families and carers. This funding will support the development of the drugs portfolio of Gain Therapeutics for the

iBASIS Accelerates Growth With JC Geha as Chief Operating Officer23.7.2019 06:00:00 CESTPress release

iBASIS, provider of communications solutions for operators and digital players worldwide, today announced the appointment of JC Geha as its COO. He will take his new post effective August 1, and be based at iBASIS’ headquarters in Lexington, Massachusetts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005757/en/ JC Geha (Photo: Business Wire) Formerly Senior Vice President, Head of International Technology and Services for Deutsche Telekom, and of Managed Services for Ericsson, Geha brings to iBASIS an impressive track record of profitable growth, technology and digital transformation expertise. His expertise spans 25 years of deep global industry relationships across the United States, Europe, Middle East, and Africa. Geha will lead iBASIS’ global operations, engineering, IT, and product development. He will report to iBASIS’ CEO and founder of the Group Tofane Global, Alexandre Pébereau, with the responsibility of g